Related Experiment Video
Updated: Aug 16, 2026

Hydrodynamic Renal Pelvis Injection for Non-viral Expression of Proteins in the Kidney
Published on: January 8, 2018
RenaGel (Geltex Pharmaceuticals Inc)
1Schwerpunkt Nephrologie Medische Klinikum, Klinikum Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany. Kai.vonAppen@lrz.uni-muenchen.de
Abstract:
RenaGel, developed by GelTex, is a polymer that binds and removes dietary phosphate from the intestinal tract without being absorbed into the bloodstream. A US NDA for control of hyperphosphatemia in patients with chronic renal failure was filed in October 1997 and accepted for review in January 1998. Marketing approval was granted in November 1998. The compound has also achieved part B status in Europe. Merrill Lynch predict RenaGel will achieve worldwide sales of $220 million by 2001.
More Related Videos
Related Concept Videos
Renal Drug Excretion: Overview
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules out...
Renal Drug Excretion: Tubular Secretion
Renal Drug Excretion: Tubular Reabsorption
Renal Drug Excretion: Glomerular Filtration
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles.
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
